McKesson Pays $190M To End Drug Price Inflation Claims
Pharmaceutical distributor McKesson Corp. will pay the federal government $190 million to settle allegations it fraudulently inflated pricing information for several brand-name prescription drugs, causing Medicaid to overpay for those drugs,...To view the full article, register now.
Already a subscriber? Click here to view full article